Skip to main content
. Author manuscript; available in PMC: 2014 Feb 20.
Published in final edited form as: Bioconjug Chem. 2013 Jan 11;24(2):196–204. doi: 10.1021/bc300473x

Figure 1.

Figure 1

Biodistribution of 64Cu-Comb and 64Cu-CANF-Comb in CWR22 tumor model following intravenous injection (n=4/group). (A) 64Cu-Comb showing low tumor accumulation but high liver uptake. (B) 64Cu-CANF-Comb showing high tumor localization and superior pharmacokinetics relative to 64Cu-Comb with high blood retention and low hepatic burden.